Waterborne Pseudomonas aeruginosa transmission in a hematology unit?

BACKGROUND: Pseudomonas aeruginosa is an important nosocomial pathogen that commonly colonizes hospital water supplies, including in taps and sinks. We report the transmission of P. aeruginosa from water to patients in a clinical hematology setting. METHODS: P. aeruginosa from water samples were compared to clinical isolates from hematology ward patients, via molecular typing (pulsed field gel electrophoresis). RESULTS: P. aeruginosa cultured from blood cultures from 3 patients was indistinguishable from water strains, by molecular typing. Based on infection control inspections, the transmission event was surmised to be due to cleaning of equipment, specifically an infusion therapy procedure tray used to transport intravenous drugs to patients, with water from an outlet colonized by P. aeruginosa. CONCLUSION: We show the importance of holistic factors, such as disposal of patient waste water, cleaning of tap outlets, and cleaning of medical equipment, in the transmission of P. aeruginosa, and demonstrate that the role of waterborne transmission of this organism in a hematology setting cannot be overlooked. We suggest that appropriate management of water, including both holistic and engineering interventions, is needed to stop transmission of P. aeruginosa from water to patients.

Engineering waterborne Pseudomonas aeruginosa out of a critical care unit.

OBJECTIVE: To describe engineering and holistic interventions on water outlets contaminated with Pseudomonas aeruginosa and the observed impact on clinical P. aeruginosa patient isolates in a large Intensive Care Unit (ICU). DESIGN: Descriptive study. SETTING: Queen Elizabeth Hospital Birmingham (QEHB), part of University Hospitals Birmingham (UHB) NHS Foundation Trust is a tertiary referral teaching hospital in Birmingham, UK and provides clinical services to nearly 1 million patients every year. METHODS: Breakpoint models were used to detect any significant changes in the cumulative yearly rates of clinical P. aeruginosa patient isolates from August 2013-December 2016 across QEHB. RESULTS: Water sampling undertaken on the ICU indicated 30% of the outlets were positive for P. aeruginosa at any one time. Molecular typing of patient and water isolates via Pulsed Field Gel Electrophoresis suggested there was a 30% transmission rate of P. aeruginosa from the water to patients on the ICU. From, February 2014, QEHB implemented engineering interventions, consisting of new tap outlets and PALL point-of-use filters; as well as holistic measures, from February 2016 including a revised tap cleaning method and appropriate disposal of patient waste water. Breakpoint models indicated the engineering and holistic interventions resulted in a significant (p<0.001) 50% reduction in the number of P. aeruginosa clinical patient isolates over a year. CONCLUSION: Here we demonstrate that the role of waterborne transmission of P. aeruginosa in an ICU cannot be overlooked. We suggest both holistic and environmental factors are important in reducing transmission.

Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria.

It was hypothesised that extracts from plants that are used as herbal medicinal products contain inhibitors of efflux in Gram-negative bacteria. Extracts from 21 plants were screened by bioassay for synergy with ciprofloxacin against Salmonella enterica serotype Typhimurium, including mutants in which acrB and tolC had been inactivated. The most active extracts, fractions and purified compounds were further examined by minimum inhibitory concentration testing with five antibiotics for activity against Enterobacteriaceae and Pseudomonas aeruginosa. Efflux activity was determined using the fluorescent dye Hoechst 33342. Eighty-four extracts from 21 plants, 12 fractions thereof and 2 purified molecules were analysed. Of these, 12 plant extracts showed synergy with ciprofloxacin, 2 of which had activity suggesting efflux inhibition. The most active extract, from Levisticum officinale, was fractionated and the two fractions displaying the greatest synergy with the five antibiotics were further analysed. From these two fractions, falcarindiol and the fatty acids oleic acid and linoleic acid were isolated. The fractions and compounds possessed antibacterial activity especially for mutants lacking a component of AcrAB-TolC. However, no synergism was seen with the fractions or purified molecules, suggesting that a combination of compounds is required for efflux inhibition. These data indicate that medicinal plant extracts may provide suitable lead compounds for future development and possible clinical utility as inhibitors of efflux for various Gram-negative bacteria.

Antibacterial terpenes from the oleo-resin of Commiphora molmol (Engl.).

Two octanordammaranes, mansumbinone (1) and 3,4-seco-mansumbinoic acid (2), and two sesquiterpenes, beta-elemene (3) and T-cadinol (4) have been isolated from the oleo-resin of Commiphora molmol (Engl.). The structures of these compounds were established unambiguously by a series of 1D and 2D-NMR analyses. We have also unambiguously assigned all (1)H and (13)C NMR resonances for 2 and revised its (13)C data. The crude extract of the oleo-resin of C. molmol displayed potentiation of ciprofloxacin and tetracycline against S. aureus, several Salmonella enterica serovar Typhimurium strains and two K. pneumoniae strains. The antibacterial activity of terpenes 1-4 was determined against a number of Staphylococcus aureus strains: SA1199B, ATCC25923, XU212, RN4220 and EMRSA15 and minimum inhibitory concentration (MIC) values were found to be in the range of 4-256 microg/ml. The highest activity was observed by the seco-A-ring octanordammarane 2 with an MIC of 4 microg/ml against SA1199B, a multidrug-resistant strain which over-expresses the NorA efflux transporter, the major characterized antibiotic pump in this species. This activity compared favorably to the antibiotic norfloxacin with an MIC of 32 microg/ml. Compound 2 also displayed weak potentiation of ciprofloxacin and tetracycline activity against strains of Salmonella enterica serovar Typhimurium SL1344 and L10.